ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,450Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 1006

$557K Total Retail Price of All Prescriptions

Rank: 181 out of 1006

412 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 412 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,598 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
HYDROCHLOROTHIAZIDE 584 554 1 11
SIMVASTATIN 474 433 2 1
ATORVASTATIN CALCIUM 340 310 3 5
FUROSEMIDE 325 309 4 6
WARFARIN SODIUM 325 325 4 8
ATENOLOL 322 322 6 13
AMLODIPINE BESYLATE 322 320 6 4
LISINOPRIL 318 306 8 3
OMEPRAZOLE 307 281 9 9
DONEPEZIL HCL 280 280 10 17
LEVOTHYROXINE SODIUM 259 259 11 2
HYDROCODONE-ACETAMINOPHEN 210 181 S3 12 25
METFORMIN HCL 202 163 13 10
METOPROLOL TARTRATE 195 184 14 7
POTASSIUM CHLORIDE 190 176 15 30
LOSARTAN POTASSIUM 178 178 16 22
PREDNISONE 174 166 17 33
SERTRALINE HCL 146 135 18 19
LIPITOR 142 135 19 47
GLIPIZIDE 127 109 20 69
CARBIDOPA-LEVODOPA 119 119 21 80
ALLOPURINOL 117 117 22 31
ZOLPIDEM TARTRATE 114 111 23 14
ALENDRONATE SODIUM 110 110 24 29
ZETIA 106 73 25 51
TAMSULOSIN HCL 103 96 26 23
METHYLPHENIDATE HCL 101 101 27 315
COUMADIN 95 95 28 235
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 71 29 38
TRICOR 85 78 30 101
DOXYCYCLINE HYCLATE 85 76 30 130
ESCITALOPRAM OXALATE 78 71 32 27
NAMENDA 75 75 33 34
PANTOPRAZOLE SODIUM 74 71 34 32
CARVEDILOL 74 74 34 36
CLOPIDOGREL 73 70 36 46
METHOTREXATE 73 69 36 183
DILTIAZEM 24HR ER 72 72 38 126
GABAPENTIN 71 68 39 20
LANOXIN 69 69 40 330
DIGOXIN 68 68 41 52
TRAZODONE HCL 67 52 42 21
AZITHROMYCIN 67 60 42 39
FLUTICASONE PROPIONATE 64 57 44 55
TRIAMCINOLONE ACETONIDE 64 49 44 135
CRESTOR 63 50 46 18
PLAVIX 62 61 47 61
PROPRANOLOL HCL 61 57 48 167
METOPROLOL SUCCINATE 57 57 49 12
ADVAIR DISKUS 57 56 49 37
LEVOFLOXACIN 56 45 51 96
OLANZAPINE 56 56 51 68
DIOVAN 55 52 53 16
TRIAMTERENE-HCTZ 54 54 54 58
COLCRYS 52 43 55 186
FINASTERIDE 51 51 56 76
NADOLOL 50 50 57 256
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.